BioGenex is at the forefront of the emerging discipline of molecular pathology, the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. The company designs, develops and commercializes systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally.
New & Improved
Polymer HRP Kits IHC
New & Improved
1-Step Polymer Kits IHC
Dr. Sharakhov’s primary research interest is in understanding the role of chromosomal inversions and heterochromatin modifications in mosquito genomes and how they pertain to the mosquito’s capability to adapt to diverse environments and change their ability to transmit malaria parasites.
Dr. Sharakhov’s, Associate Professor
My experience with EZ-Retrievel is great, a comfortable and safe system when performed antigenic recovery for conventional IHC and multiple-IHC. I never had a problem with my tissues and the quality of the results were very reproducible. Thanks!!!
Erick Riquelme, Assistant Professor
Our all-inclusive, Super SensitiveTM Detection…
ISH is an ideal cost-effective approach that…
48810 Kato Road,
Suite 200E, Fremont,
CA 94538 – USA